Brevan Howard Capital Management LP Editas Medicine, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 30,116 shares of EDIT stock, worth $40,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,116
Previous 79,068
61.91%
Holding current value
$40,355
Previous $369,000
72.36%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EDIT
# of Institutions
248Shares Held
57.1MCall Options Held
410KPut Options Held
394K-
Black Rock Inc. New York, NY7.78MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.68MShares$8.95 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$6.57 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$4.49 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$3.3 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $92.1M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...